Newsletters
The spring edition of our macular degeneration research newsletter explores new treatments that are on the horizon, what to expect when it comes to injections, and more.
Learn about research exploring the mechanisms of eye pressure regulation, which could lead to improved glaucoma treatments, five tips for using glaucoma eye drops, information about childhood glaucoma, and more in the winter edition of the winter edition of our glaucoma newsletter.
Download the fall edition of our macular degeneration research newsletter and read about new treatments that are on the horizon, the latest research grants awarded for pioneering macular degeneration research, the first-ever bionic eye for patients with macular degeneration, and more.
Learn about a BrightFocus grantee's role in confirming amyloid's role in early Alzheimer's, a record-breaking $5.9 million in new Alzheimer's research awarded by BrightFocus Foundation, how to be prepared if you need to search for someone who has Alzheimer's disease, and more, in the winter edition of our Alzheimer's disease newsletter.
Explore the mystery of normal-tension glaucoma, a medication that may reduce the risk of open-angle glaucoma, learn about 15 new glaucoma research grants awarded by BrightFocus Foundation, and more in the fall edition of our glaucoma newsletter.
Download the summer edition of our Alzheimer's disease newsletter and learn about a cancer drug that shows early promise as an Alzheimer's treatment, a new drug that passes early clinical trial tests in humans, and other helpful information.
Download the summer 2015 issue of our macular degeneration newsletter to learn about a new AMD treatment that is close to human clinical trials, how cataract surgery affects AMD, AREDS vitamins. risk reduction strategies for AMD, and more.
Download the summer 2015 issue of our glaucoma newsletter to learn about how a healthy diet leads to healthy eyes, how to make your computer vision-friendly, and much more.
Download the fall 2013 issue of our glaucoma newsletter to learn about an FDA-approved glaucoma drug called Simbrinza™ Suspension, strategies for everyday life with glaucoma, and much more.
Download the winter 2014 issue of our glaucoma newsletter to learn about a recently discovered common genetic marker for elevated intraocular pressure, risks associated with certain glaucoma drugs, and much more.